Is Miravant Medical Technologies halal to invest in?

According to Musaffa's Shariah screening methodology, Miravant Medical Technologies (MRVT) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Miravant Medical Technologies a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Miravant Medical Technologies using these criteria to determine its compliance status.

Can Muslims buy shares of Miravant Medical Technologies?

Muslim investors may consider investing in Miravant Medical Technologies if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Miravant Medical Technologies classified as NOT COVERED?

Musaffa determines the Shariah status of Miravant Medical Technologies by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Miravant Medical Technologies updated?

The Shariah compliance status of Miravant Medical Technologies may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Miravant Medical Technologies become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Miravant Medical Technologies?

You can check the latest Shariah compliance status of Miravant Medical Technologies on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Miravant Medical Technologies. Stock Analysis MRVT

United States N/A Nano Cap

Miravant Medical Technologies engages in the research and development of drugs and medical device products for the use in proprietary technologies for photodynamic therapy. The company is headquartered in Santa Barbara, California and currently employs 47 full-time employees. The drug and light procedures involve three components, the photoselective drugs, light producing devices and light delivery devices. The firm's products have been developed in-house and with outside collaborators and have been used in various clinical and preclinical investigations. Its most advanced drug, PHOTREX, generic name rostaporfin, has completed two Phase III clinical trials for the treatment of wet age-related macular degeneration (AMD). Miravant has branded its version of PDT technology with the trademark PhotoPoint.

Financial Metrics & Statements of Miravant Medical Technologies (MRVT)

FAQ's for Miravant Medical Technologies (MRVT)

According to Musaffa’s Shariah screening methodology, Miravant Medical Technologies (MRVT) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.